tetano
Editor, Senior Moderator
East Mediterr Health J. 2016 Oct 2;22(7):453-459.
[h=1]Detection of influenza B viruses with reduced sensitivity to neuraminidase inhibitor in Morocco during 2014/15 season.[/h] Elfalki F[SUP]1[/SUP], Ihazmad H[SUP]2[/SUP], Bimouhen A[SUP]2[/SUP], Regragui Z[SUP]2[/SUP], Benkaroum S[SUP]2[/SUP], Bakri Y[SUP]3[/SUP], Barakat A[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We monitored phenotypic and genotypic susceptibility of influenza viruses circulating in Morocco during 2014-2015 to oseltamivir and zanamivir. Throat and nasal swab specimens were collected from outpatients (with influenza-like illness) and inpatients (with severe acute respiratory illness) and tested for influenza viruses using real-time reverse transcription polymerase chain reaction. Positive samples were inoculated in MDCK cells and virus phenotypic susceptibility to neuraminidase inhibitors (NAIs) was assessed using fluorescent NA inhibition. Of 440 specimens, 135 were positive for influenza B Yamagata-like virus, 38 were A(H1N1)pdm09 and 25 were A(H3N2). Sixty influenza B viruses isolated from MDCK cells showed no significant resistance to NAIs. However, two of these strains, B/Morocco/176H/2015 and B/Morocco/CP10/2015, showed reduced susceptibility to oseltamivir. The two influenza B viruses with reduced susceptibility to oseltamivir show that ongoing NAI susceptibility surveillance is essential.
PMID: 27714739
[PubMed - in process]
[h=1]Detection of influenza B viruses with reduced sensitivity to neuraminidase inhibitor in Morocco during 2014/15 season.[/h] Elfalki F[SUP]1[/SUP], Ihazmad H[SUP]2[/SUP], Bimouhen A[SUP]2[/SUP], Regragui Z[SUP]2[/SUP], Benkaroum S[SUP]2[/SUP], Bakri Y[SUP]3[/SUP], Barakat A[SUP]2[/SUP].
[h=3]Author information[/h]
[h=3]Abstract[/h] We monitored phenotypic and genotypic susceptibility of influenza viruses circulating in Morocco during 2014-2015 to oseltamivir and zanamivir. Throat and nasal swab specimens were collected from outpatients (with influenza-like illness) and inpatients (with severe acute respiratory illness) and tested for influenza viruses using real-time reverse transcription polymerase chain reaction. Positive samples were inoculated in MDCK cells and virus phenotypic susceptibility to neuraminidase inhibitors (NAIs) was assessed using fluorescent NA inhibition. Of 440 specimens, 135 were positive for influenza B Yamagata-like virus, 38 were A(H1N1)pdm09 and 25 were A(H3N2). Sixty influenza B viruses isolated from MDCK cells showed no significant resistance to NAIs. However, two of these strains, B/Morocco/176H/2015 and B/Morocco/CP10/2015, showed reduced susceptibility to oseltamivir. The two influenza B viruses with reduced susceptibility to oseltamivir show that ongoing NAI susceptibility surveillance is essential.
PMID: 27714739
[PubMed - in process]